Erwinase: Clinical Trials

4 trials of Erwinase, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting, 1 terminated. 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 14Completed 2, Recruiting 1, Terminated 1

Follow Erwinase: new trials by email Literature Review of Erwinase trials Research Report on Erwinase

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Recombinant Erwinia Asparaginase and Venetoclax in Combination With Blinatumomab for the Treatment of Relapsed or Refractory CD19 Positive B-cell Acute Lymphoblastic Leukemia
Asparaginase Erwinia chrysanthemi, Biospecimen Collection, Blinatumomab - Recurrent B Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia
Phase 1RecruitingCity of Hope Medical Center262026-05-132026-10-16
1336GCC: Study of Erwinaze for Treatment of Acute Myeloid Leukemia (AML)
Erwinase - Acute Myeloid Leukemia
Phase 1CompletedAshkan Emadi52014-04-012018-03-12
Erwinase for Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (IND 104224)
Erwinase, Vincristine, Dexamethasone - Relapsed Acute Lymphoblastic Leukemia, Allergy to PEG e.Coli Asparaginase
Phase 1TerminatedTherapeutic Advances in Childhood Leukemia Consortium12009-04-132019-02-19
Compassionate Use of Erwinase For Pediatric Patients With Acute Lymphoblastic Leukemia Or Non Hodgkins Lymphoma
Erwinase - Acute Lymphoblastic Leukemia, Non Hodgkins Lymphoma
Phase 1CompletedSt. Jude Children's Research Hospital872006-06-012017-04-26

Conditions studied

Precursor Cell Lymphoblastic Leukemia-Lymphoma (2)  ·  Burkitt Lymphoma (1)  ·  Hypersensitivity (1)  ·  Leukemia (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Recurrence (1)

Sponsors

Ashkan Emadi (1)  ·  City of Hope Medical Center (1)  ·  St. Jude Children's Research Hospital (1)  ·  Therapeutic Advances in Childhood Leukemia Consortium (1)

Countries

United States (4)

Top investigators

Amandeep Salhotra (1)  ·  Ashkan Emadi, MD, PhD (1)  ·  Heather Grossman, MD (1)  ·  Paul Gaynon, MD (1)  ·  Sima Jeha, MD (1)

NIH funding

P30CA033572 (1)